CI & Patent News:26/11/2010


Pronova BioPharma receives Lovaza(TM) Paragraph IV Notice Letter from Apotex Inc (Press release)

Impax Laboratories Confirms Patent Challenge Relating to SIMCOR® Extended-Release Tablets, 1000/20 mg (link)

Paragraph IV litigation:

1) Merck & Co., Inc Vs Hetero Drugs & Invagen Pharmaceuticals (No patent/product traced); Filed on November 19, 2010

2) Ortho-McNeil Vs Mylan & Famycare (Product may be “Ortho Tri-Cyclen”) filed on November 12, 2010; Famycare and Mylan have tie up for USA contraceptive market;  As per thier agreement two companies will jointly file ANDA for approval of at least 22 new oral contraceptives with the US FDA (Link).

For these two litigation will be updated soon with patent details

Advertisements

About Guna

Interested to learn things around me
This entry was posted in Daily interesting IP news and tagged , , , , , , , . Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s